Location History:
- Wyndmoor, PA (US) (1990)
- Irvine, CA (US) (1991)
Company Filing History:
Years Active: 1990-1991
Title: Innovations of Gabriel F Eilon in Malaria Treatment
Introduction
Gabriel F Eilon is a notable inventor based in Wyndmoor, Pennsylvania, recognized for his contributions to the field of medicine, particularly in the treatment of malaria. With a total of two patents to his name, Eilon has made significant strides in developing methods to combat this life-threatening disease.
Latest Patents
Eilon's latest patents include a method of treating malaria with cyproheptadine derivatives. This innovation involves various 3-substituted cyproheptadine derivatives that are effective in treating infections caused by Plasmodium falciparum. These compounds can be utilized either as standalone treatments or in combination with other antimalarial agents. Additionally, he has developed methods for treating malaria and infections by Plasmodium falciparum. Another patent focuses on N-(N-succinyl-L-leucyl)agmatine and related compounds, which have specific chemical formulas that demonstrate potential therapeutic applications.
Career Highlights
Eilon is currently associated with Merck & Company, Inc., a leading global healthcare company. His work at Merck has allowed him to contribute to groundbreaking research and development in pharmaceuticals, particularly in the area of infectious diseases.
Collaborations
Throughout his career, Eilon has collaborated with esteemed colleagues, including John J Baldwin and Paul A Friedman. These partnerships have fostered an environment of innovation and have led to advancements in medical treatments.
Conclusion
Gabriel F Eilon's work in developing innovative treatments for malaria showcases his dedication to improving global health. His patents reflect a commitment to finding effective solutions for combating infectious diseases.